Regulation of the cancer cell motility by Racl GTPase: implications for metastasis of colon cancer
Regulation of the cancer cell motility by Racl GTPase: implications for metastasis of colon cancer
批准号:
13670563
负责人:
NAKANO Masaru
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It is well accepted that cancer cells are biologically heterogeneous and metastatic capability is one of the most prominent heterogeneous property of cancer cells. Recent progress revealed that cancer cell motility, which is quite different from cell to cell, plays a central role in a tumor metastasis. Initial step of cell migration is extension of active membrane processes, including both lamellipodia and filopodia, which takes place primarily around cell front with cell locomotion taking on a persistent random walk. Assembly of actin filament drives the locomotion of tumor cells. Expansion of dense net work of action filaments underlying the plasma membrane provides sufficient force to push forward the leading edge. These processes are regulated Rho family GTPases. The basic signaling properties of two major subgroups of Rho GTPases-the Rac and Cdc42 sub families-are highlyconserved among alleukaryotes, but the means by which they act in cancer cell are not well understood. Recent evidence indicated that Rho activationplay some role in hepatoma and prostate cancer cell migration and invasion. Although cells transfected with active mutant Rac or Cdc42 CDNA in vitroacquired high motility, any cancer tissues or cell lines have not been found to have similar mutations in Rac or Cdc42 gene so that the roles of Racand Cdc42 sub families in cancer cells are not well understood. Here we report that some colon cancer cell lines maintains high GTP bound form Rac-active Rac-and high invasive ability. Interestingly Rho activation which induces high motility of some hepatoma inhibited motility of those colon cancer cells with high active Rac. Another unexpected finding was that there were no significant differences in Cdc42 active state in colon cancer celllines. This finding indicates that Rac as well as Rho not cdc42 are the major Rho family GTPases to regulate colon cancer cell motility.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Malliri A, van der Kamraen RA, Collard JG et al.: "Mice deficient in the Rao activator Tiaml are resistant to Ras-induced skin tumours"Nature. 417(6891). 867-871 (2002)
Malliri A、van der Kamraen RA、Collard JG 等人:“缺乏 Rao 激活剂 Tiaml 的小鼠能够抵抗 Ras 诱导的皮肤肿瘤”Nature。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Zondag GC, Evers EE, Collard JG et al.: "Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-Biesenchymal transition"J Cell Biol. 149(4). 775-782 (2000)
Zondag GC、Evers EE、Collard JG 等人:“致癌 Ras 下调 Rac 活性,从而导致 Rho 活性增加和上皮-双质转化”J Cell Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ng J, Nardine T, Luo L et al.: "Rac CTPases control axon growth, guidance and branching"Nature. 416(6879). 442-447 (2002)
Ng J,Nardine T,Luo L 等:“Rac CTPases 控制轴突生长、引导和分支”Nature。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Quinlan MP: "Rac regulates the stability of the adherens junctionand its components, thus affecting epithelial cell differentiation and transformation"Oncogene. 18(47). 6434-6442 (1999)
Quinlan MP:“Rac调节粘附连接及其成分的稳定性,从而影响上皮细胞的分化和转化”癌基因。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Engers R, Springer E, Gabbert HE et al.: "Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-l and TIMP-2 expression"J Biol Chem.. 276(45). 41889-41897 (2001)
Engers R、Springer E、Gabbert HE 等人:“Rac 通过上调金属蛋白酶组织抑制剂 (TIMP)-1 和 TIMP-2 的表达来影响人肾细胞癌的侵袭”J Biol Chem. 276(45)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Tandem mass spectrometry-based creatinine measurement using dried blood spot for newborn mass screening.
-
批准号:19K17371
-
项目类别:Grant-in-Aid for Early-Career Scientists
-
资助金额:$2.75万
-
财政年份:2019
-
负责人:NAKANO Masaru
-
依托单位:
Development of an Educational Game for Sustainable Supply Chains
-
批准号:26380475
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2014
-
负责人:NAKANO Masaru
-
依托单位:
Production of interspecific and intergeneric hybrids and analysis of genetic relationship in colchicaceous ornamentals
-
批准号:20580023
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:NAKANO Masaru
-
依托单位:
Flower form alteration in monocot ornamental plants by genetic transformation
-
批准号:16380024
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.05万
-
财政年份:2004
-
负责人:NAKANO Masaru
-
依托单位:
A fundamental research for genetic transformation via microprotoplast fusion in Liliaceous species
-
批准号:13660024
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2001
-
负责人:NAKANO Masaru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TGF-β/lnc-APUE/ZEB1通路促进肝癌转移的机制及生物学意义
-
批准号:32100616
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李颂扬
-
依托单位:
乳腺癌细胞外泌体miRNA诱导组蛋白修饰表观调控巨噬细胞M2极化的机制探索
-
批准号:31960152
-
项目类别:地区科学基金项目
-
资助金额:39.0万元
-
批准年份:2019
-
负责人:罗达亚
-
依托单位:
内质网蛋白Ei24调控胰腺癌细胞迁移、侵袭的分子机制研究
-
批准号:31970704
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2019
-
负责人:袁琳
-
依托单位:
泛素连接酶TRIM65通过RhoGAP调控Rho活性促进结直肠癌侵袭转移的分子机制
-
批准号:31970703
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2019
-
负责人:陈代词
-
依托单位:
HDAC11去ε-氨基长链脂肪酰化机制及功能的研究
-
批准号:31970749
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:孙蕾
-
依托单位:
FSTL1诱导结直肠癌相关成纤维细胞活化的分子机制研究
-
批准号:31900569
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:谷川莎
-
依托单位:
E3泛素连接酶RNF8在肺癌转移中的作用及机制研究
-
批准号:31900537
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:匡静宇
-
依托单位:
靶向纳米颗粒调控HIF-1α通路抑制缺氧三阴性乳腺癌耐药和转移的研究
-
批准号:31900567
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:田浩
-
依托单位:
癌蛋白TBC1D3与β-肌动蛋白“对话”促进乳腺癌细胞迁移的分子机制
-
批准号:31801171
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:王北
-
依托单位:
ARHGEF39通过与STRAP相互作用激活TGF-β/Smad信号通路而促进肝癌侵袭转移的机制研究
-
批准号:81802917
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:王海啸
-
依托单位: